tiprankstipranks
Trending News
More News >

Cogent Biosciences price target lowered to $7 from $8 at Baird

Baird lowered the firm’s price target on Cogent Biosciences (COGT) to $7 from $8 and keeps a Neutral rating on the shares. The firm updated its model following Q1 results and the first major readout for its pivotal SUMMIT data in NonAdvSm is on track for July.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue